Gabriel (Gabe) Otte is the CEO and Co-Founder of Freenome, a health technology company reinventing disease management through systematized early detection and intervention. Freenome’s goal is, in Gabe’s words, to bring “accurate, accessible and non-invasive disease screenings to doctors to proactively treat cancer and other diseases when they can be treated” Simply put: to detect diseases earlier when they can be cured. Gabe previously worked as a software engineer at both Apple and the Glyde corporation. He earned an undergraduate degree in chemistry and computational biology from Cornell and did graduate work at the University of Pennsylvania.